These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4026877)

  • 1. The characterization of [3H]sulpiride binding sites in pig striatal membranes.
    Holden-Dye L; Poat JA; Senior K; Woodruff GN
    Biochem Pharmacol; 1985 Aug; 34(16):2905-9. PubMed ID: 4026877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations.
    Freedman SB; Poat JA; Woodruff GN
    J Neurochem; 1981 Sep; 37(3):608-12. PubMed ID: 7276943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sodium and sulphydryl groups on [3H]sulpiride binding sites in rat striatal membranes.
    Freedman SB; Poat JA; Woodruff GN
    J Neurochem; 1982 May; 38(5):1459-65. PubMed ID: 7062062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of guanosine nucleotides of [3H]sulpiride binding to rat striatal membranes.
    Freedman SB; Poat JA; Woodruff GN
    Eur J Pharmacol; 1981 Jan; 69(1):117-8. PubMed ID: 7202509
    [No Abstract]   [Full Text] [Related]  

  • 5. The characterization of [3H]sulpiride binding sites in rat striatal membranes.
    Imafuku J
    Brain Res; 1987 Feb; 402(2):331-8. PubMed ID: 3828800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of [3H]sulpiride to purified rat striatal synaptic membranes.
    Woodruff GN; Freedman SB
    Neuroscience; 1981; 6(3):407-10. PubMed ID: 7219722
    [No Abstract]   [Full Text] [Related]  

  • 9. Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites.
    Theodorou AE; Jenner P; Marsden CD
    Life Sci; 1983 Mar; 32(11):1243-54. PubMed ID: 6834988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the localization of [3H]sulpiride binding sites in rat striatal membranes.
    Freedman SB; Mustafa AA; Poat JA; Senior KA; Wait CP; Woodruff GN
    Neuropharmacology; 1981 Dec; 20(12A):1151-5. PubMed ID: 6119635
    [No Abstract]   [Full Text] [Related]  

  • 11. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons.
    Theodorou A; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1981 Jul; 33(7):439-44. PubMed ID: 6115030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of [3H]sulpiride to rat striatal preparations.
    Theodorou A; Crockett M; Jenner P; Marsden CD
    J Pharm Pharmacol; 1979 Jun; 31(6):424-6. PubMed ID: 39154
    [No Abstract]   [Full Text] [Related]  

  • 14. 3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites.
    Sokoloff P; Redouane K; Brann M; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):236-43. PubMed ID: 4022135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.
    Martres MP; Sokoloff P; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of some of the properties of the [3H]-sulpiride binding site in soluble and native membrane preparations of dog striatum.
    Templeton WW; Woodruff GN
    Br J Pharmacol; 1983 Jan; 78(1):5-7. PubMed ID: 6824816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H] (-)sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay.
    Stefanini E; Ortu AM; Vernaleone F; Gessa GL
    Pharmacol Res Commun; 1987 Nov; 19(11):777-91. PubMed ID: 3444842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.